Yuanqing Wu

1.3k total citations
22 papers, 799 citations indexed

About

Yuanqing Wu is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Yuanqing Wu has authored 22 papers receiving a total of 799 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Pharmacology and 4 papers in Cancer Research. Recurrent topics in Yuanqing Wu's work include Inflammatory mediators and NSAID effects (7 papers), Microbial Metabolic Engineering and Bioproduction (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Yuanqing Wu is often cited by papers focused on Inflammatory mediators and NSAID effects (7 papers), Microbial Metabolic Engineering and Bioproduction (5 papers) and Peroxisome Proliferator-Activated Receptors (4 papers). Yuanqing Wu collaborates with scholars based in China, United States and Poland. Yuanqing Wu's co-authors include Imad Shureiqi, Scott M. Lippman, Xiangsheng Zuo, Jeffrey S. Morris, Susan M. Fischer, Julie B. Stimmel, Lisa M. Leesnitzer, Russell R. Broaddus, Wei Jiang and Micheline J. Moussalli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Cancer Research.

In The Last Decade

Yuanqing Wu

21 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuanqing Wu China 15 497 276 179 125 106 22 799
Uddhav P. Kelavkar United States 14 291 0.6× 221 0.8× 186 1.0× 143 1.1× 109 1.0× 25 653
Russell D. Klein United States 20 524 1.1× 305 1.1× 246 1.4× 138 1.1× 290 2.7× 24 1.1k
Xian-Zhong Ding United States 10 450 0.9× 244 0.9× 192 1.1× 46 0.4× 43 0.4× 10 782
Angela M. Acquaviva Italy 19 427 0.9× 294 1.1× 145 0.8× 60 0.5× 177 1.7× 33 1.1k
Thorsten J. Maier Germany 14 247 0.5× 190 0.7× 72 0.4× 93 0.7× 65 0.6× 24 670
Gi‐Ryang Kweon South Korea 17 478 1.0× 112 0.4× 243 1.4× 147 1.2× 50 0.5× 26 1.0k
Steve Perry United States 13 337 0.7× 124 0.4× 120 0.7× 123 1.0× 33 0.3× 18 737
Amy Pavone United States 15 313 0.6× 153 0.6× 135 0.8× 39 0.3× 91 0.9× 30 726
Leigh C. Wilson United States 8 508 1.0× 253 0.9× 147 0.8× 84 0.7× 123 1.2× 8 1.2k
María M. Facchinetti Argentina 18 879 1.8× 93 0.3× 140 0.8× 53 0.4× 106 1.0× 42 1.1k

Countries citing papers authored by Yuanqing Wu

Since Specialization
Citations

This map shows the geographic impact of Yuanqing Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuanqing Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuanqing Wu more than expected).

Fields of papers citing papers by Yuanqing Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuanqing Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuanqing Wu. The network helps show where Yuanqing Wu may publish in the future.

Co-authorship network of co-authors of Yuanqing Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Yuanqing Wu. A scholar is included among the top collaborators of Yuanqing Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuanqing Wu. Yuanqing Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Fei, Di Deng, Yuanqing Wu, et al.. (2025). Multidimensional Engineering of Escherichia coli for Efficient Adipic Acid Synthesis From Cyclohexane. Advanced Science. 12(14). e2411938–e2411938. 1 indexed citations
2.
Wu, Yuanqing, Shusen Zheng, Zhibin Yang, et al.. (2025). Integrated protein and metabolic engineering enable high-yield biosynthesis of resveratrol derivatives in Yarrowia lipolytica. Synthetic and Systems Biotechnology. 10(4). 1368–1376.
3.
Wu, Yuanqing, et al.. (2024). Enhancing Gastrodin Production in Yarrowia lipolytica by Metabolic Engineering. ACS Synthetic Biology. 13(4). 1332–1342. 6 indexed citations
5.
Wu, Yuanqing, et al.. (2020). Enhancing β-Carotene Production in Escherichia coli by Perturbing Central Carbon Metabolism and Improving the NADPH Supply. Frontiers in Bioengineering and Biotechnology. 8. 585–585. 42 indexed citations
6.
Zhu, Jingyu, Yuanqing Wu, Man Wang, et al.. (2020). Integrating Machine Learning-Based Virtual Screening With Multiple Protein Structures and Bio-Assay Evaluation for Discovery of Novel GSK3β Inhibitors. Frontiers in Pharmacology. 11. 566058–566058. 32 indexed citations
7.
Wu, Yuanqing, Xue‐Wei Liu, Zhiwen Wang, et al.. (2019). Combinatorial expression of different β-carotene hydroxylases and ketolases in Escherichia coli for increased astaxanthin production. Journal of Industrial Microbiology & Biotechnology. 46(11). 1505–1516. 21 indexed citations
9.
Han, Li, Pi Liu, Jixue Sun, et al.. (2015). Engineering catechol 1, 2-dioxygenase by design for improving the performance of the cis, cis-muconic acid synthetic pathway in Escherichia coli. Scientific Reports. 5(1). 13435–13435. 32 indexed citations
10.
Zuo, Xiangsheng, Min Xu, Yu Jiang, et al.. (2014). Potentiation of Colon Cancer Susceptibility in Mice by Colonic Epithelial PPAR-δ/β Overexpression. JNCI Journal of the National Cancer Institute. 106(4). dju052–dju052. 48 indexed citations
11.
Wu, Yuanqing, Yuanyuan Zhang, Ran Tu, Hao Liu, & Qinhong Wang. (2013). [Construction of synthetic promoters for Escherichia coli and application in the biosynthesis of cis,cis-muconic acid].. PubMed. 29(6). 760–71. 4 indexed citations
12.
Zuo, Xiangsheng, Zhanglong Peng, Yuanqing Wu, et al.. (2012). Effects of Gut-Targeted 15-LOX-1 Transgene Expression on Colonic Tumorigenesis in Mice. JNCI Journal of the National Cancer Institute. 104(9). 709–716. 35 indexed citations
13.
Moussalli, Micheline J., Yuanqing Wu, Xiangsheng Zuo, et al.. (2011). Mechanistic Contribution of Ubiquitous 15-Lipoxygenase-1 Expression Loss in Cancer Cells to Terminal Cell Differentiation Evasion. Cancer Prevention Research. 4(12). 1961–1972. 37 indexed citations
14.
Wu, Yuanqing, Bingliang Fang, Xiulan Yang, et al.. (2008). Therapeutic Molecular Targetingof 15-Lipoxygenase-1 in Colon Cancer. Molecular Therapy. 16(5). 886–892. 29 indexed citations
15.
Shureiqi, Imad, Xiangsheng Zuo, Russell R. Broaddus, et al.. (2006). The transcription factor GATA‐6 is overexpressed in vivo and contributes to silencing 15‐LOX‐1 in vitro in human colon cancer. The FASEB Journal. 21(3). 743–753. 50 indexed citations
16.
Zuo, Xiangsheng, Yuanqing Wu, J. Steven Morris, et al.. (2005). Oxidative metabolism of linoleic acid modulates PPAR-beta/delta suppression of PPAR-gamma activity. Oncogene. 25(8). 1225–1241. 98 indexed citations
17.
Hsi, Linda C., et al.. (2005). The methyltransferase inhibitor 5-aza-2-deoxycytidine induces apoptosis via induction of 15-lipoxygenase-1 in colorectal cancer cells. Molecular Cancer Therapeutics. 4(11). 1740–1746. 40 indexed citations
18.
Shureiqi, Imad, Yuanqing Wu, Dongning Chen, et al.. (2005). The Critical Role of 15-Lipoxygenase-1 in Colorectal Epithelial Cell Terminal Differentiation and Tumorigenesis. Cancer Research. 65(24). 11486–11492. 78 indexed citations
19.
Shureiqi, Imad, Wei Jiang, Xiangsheng Zuo, et al.. (2003). The 15-lipoxygenase-1 product 13- S -hydroxyoctadecadienoic acid down-regulates PPAR-δ to induce apoptosis in colorectal cancer cells. Proceedings of the National Academy of Sciences. 100(17). 9968–9973. 191 indexed citations
20.
Wu, Yuanqing, et al.. (1999). A DGGE system for comprehensive mutation screening of the complete coding regions of BRCA1 and BRCA2 outside exons 11. Data Archiving and Networked Services (DANS). 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026